Trial
NCT04315155
Evaluating Safety & Efficacy Belinostat Combo w Nivo Alone & w Ipi in Patients w Treated Metastatic/Advanced Carcinomas w ARID1A Lof Mutation
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
Bristol-Myers Squibb; Acrotech Biopharma Inc.
Condition
Metastatic Adenocarcinoma
Intervention
Belinostat
Why stopped
study abandoned for funding issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-28